We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





MEDLAB Middle East and Arab Health 2022 Edition Return as Co-Located Events for Healthcare and Laboratory Industries

By LabMedica International staff writers
Posted on 24 Jan 2022

Technology took centre stage at the 2022 edition of Arab Health and MEDLAB Middle East, the largest healthcare and laboratory exhibitions in the MENA region, organized by Informa Markets (London, UK).

The co-located events took place at the Dubai World Trade Centre from January 24-27 under the show themes of ‘United by business, forging ahead’ and ‘Connect with innovation that’s changing the face of diagnostics’. Both shows saw participants from nearly 160 countries and more than 60,000 attendees across the four days, with almost 4,000 exhibitors from the healthcare and laboratory industries.

More than 60 countries were represented, with over 20 dedicated country pavilions, making Arab Health and MEDLAB Middle East a genuinely global healthcare showcase. They included the UAE, Israel, Lebanon, Turkey, and a host of European countries such as the UK, Switzerland, Germany, Italy, France, Spain, Portugal, Slovenia, Hungary, Czech Republic, Poland, and Belgium. Russia, China, Taiwan, Japan, Korea, India, the US and Canada also had several exhibitors showcasing the latest technology and innovation through a range of healthcare products. Each pavilion hosted between 16 and 33 healthcare-related companies. In addition, the European Innovation Council Pavilion hosted 20 selected companies from across the healthcare landscape.

Underscoring the focus on technology, Arab Health 2022 featured the new Healthcare Transformation Zone which explored the latest tech advancements from global innovators and disruptors. The popular start-up competition, Innov8 Talks returned and featured 24 companies showcasing unique and innovative solutions. Rounding out the Transformation Zone was the launch of the Product Showcase segment, where a range of companies showcased ground-breaking innovations shaping the future of the healthcare and laboratory industries.

In another first for both events was the launch of the Future Health Summit. The high-level event was attended by over 150 senior government healthcare officials, CEOs and visionaries, from across the globe. As part of the Arab Health Congress, more than 550 regional and international speakers and over 2,500 delegates participated in 12 Continuing Medical Education (CME). With a total of nine conferences, MEDLAB Middle East Congress remains one of the largest CME accredited multi-track medical laboratory congresses globally, featuring over 100 renowned laboratory champions from around the world. Eight conferences took place live, in-person, and online, the new bonus track, Future of Lab.

"Arab Health and Medlab Middle East will once again reiterate the importance of the healthcare and laboratory industries as we continue to address the challenges posed by COVID-19 and provide a platform for developing solutions to overcome the pandemic," said Solenne Singer, Group Director for Informa Markets. "We have witnessed a clear uptick in demand from both buyers and exhibitors eager to meet in-person, to see firsthand the latest technology and innovation on the market, while also hearing from industry professionals from around the world on the latest trends and insights. This year, both events will be integral to ongoing global recovery, and we look forward to welcoming the industry to Dubai."

Related Links:
Informa Markets 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Myeloperoxidase Assay
IDK MPO ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.